TSHA
#2170
Taysha Gene Therapies, Inc. - Common Stock
5.3 7 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.19%
Monthly Change
-7.73%
6 month change
+6.55%
Year Change
+102.64%
Previous Close
5.3 8
Open
5.3 8
Low
5.3 1
High
5.4 7
Volume
369
Financials
- Market Capitalization 1.54 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-16.18
Price to sales ratio
179.93
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2159 |  AVBP ArriVent BioPharma, Inc. - Common Stock | 32.96 USD | -2.02% | -4.38% | +7.29% | +50.30% | 1.54 B USD | ||
| 2168 |  SEPN Septerna, Inc. - Common Stock | 34.23 USD | -0.38% | -5.57% | -5.62% | +55.52% | 1.54 B USD | ||
| 2185 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 20.24 USD | -0.83% | +7.72% | +7.37% | +111.72% | 1.49 B USD | ||
| 2204 |  NVAX Novavax, Inc. - Common Stock | 8.82 USD | -1.01% | -1.89% | -3.82% | +25.64% | 1.45 B USD |
Frequently asked questions about Taysha Gene Therapies, Inc. - Common Stock
What is the Taysha Gene Therapies, Inc. - Common Stock stock price today?
The current price of Taysha Gene Therapies, Inc. - Common Stock (TSHA) is 5.37. Over the past 24 hours, the stock has changed by -0.19%. Follow the TSHA chart for real-time price dynamics.
What is the stock ticker of Taysha Gene Therapies, Inc. - Common Stock?
Taysha Gene Therapies, Inc. - Common Stock trades under the ticker TSHA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Taysha Gene Therapies, Inc. - Common Stock stock going up?
TSHA has changed by -16.49% over the last week, -7.73% over the last month, and +102.64% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Taysha Gene Therapies, Inc. - Common Stock net income for the last quarter?
Taysha Gene Therapies, Inc. - Common Stock reported net income of -42.41 M for the last quarter. The previous quarter showed -27.85 M, which means net income changed by -52.27%.
How many employees does Taysha Gene Therapies, Inc. - Common Stock have?
As of the latest available data, Taysha Gene Therapies, Inc. - Common Stock has 99 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Taysha Gene Therapies, Inc. - Common Stock stock?
You can buy Taysha Gene Therapies, Inc. - Common Stock (TSHA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Taysha Gene Therapies, Inc. - Common Stock stock?
Investing in Taysha Gene Therapies, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TSHA chart and related analysis on metatrader.com as part of your research.